NASDAQ / LIVE COMPANY INTELLIGENCE

Oaktree Acquisition Corp. III Life Sciences

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKEROACC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / OACC COVERAGE

What’s moving Oaktree Acquisition Corp. III Life Sciences now

Current reporting with the operating signal separated from the noise.

01
TradingView

Oaktree Acquisition Corp. III Life Sciences Revenue Breakdown – BOATS:OACCW

Investors are testing whether Oaktree Acquisition Corp. III Life Sciences’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest OACC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2025-10-29 · Period 2025-10-29SEC ↗8-KMaterial company eventFiled 2025-10-17 · Period 2025-10-17SEC ↗8-KMaterial company eventFiled 2025-06-06 · Period 2025-06-03SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-15SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-11SEC ↗
EARNINGS / QUARTERLY TRACKER

Oaktree Acquisition Corp. III Life Sciences, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.